(Q43250339)

17 November 2017

title

In vitro evidence for the formation of reactive intermediates of resveratrol in human liver microsomes (English)

1 reference

17 November 2017

R C Steenwyk

1

1 reference

17 November 2017

B Tan

series ordinal

2

1 reference

17 November 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

17 November 2017

1 reference

17 November 2017

volume

40

1 reference

17 November 2017

issue

1

1 reference

17 November 2017

page(s)

62-71

1 reference

Resveratrol improves health and survival of mice on a high-calorie diet

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00498250903337384

Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903337384

Molecular mechanism of the chemopreventive effect of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903337384

4-Hydroxylated metabolites of the antiestrogens tamoxifen and toremifene are metabolized to unusually stable quinone methides.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903337384

Mechanism-based in vitro screening of potential cancer chemopreventive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903337384

Toxicogenomics of resveratrol in rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903337384

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903337384

Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903337384

Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903337384

Resveratrol: from grapevines to mammalian biology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903337384

Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903337384

The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903337384

Determination of piceatannol in rat serum and liver microsomes: pharmacokinetics and phase I and II biotransformation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903337384

Uptake of diet resveratrol into the human low-density lipoprotein. Identification and quantification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903337384

High absorption but very low bioavailability of oral resveratrol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903337384

Identification of the major metabolites of resveratrol in rat urine by HPLC-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903337384

Human, rat, and mouse metabolism of resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903337384

Transport of thalidomide by the human intestinal caco-2 monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498250903337384

10.3109/00498250903337384

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference